Decker Retirement Planning’s Alnylam Pharmaceuticals ALNY Stock Holding History

Decker Retirement Planning’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$301	Buy	+1	New	+$302	﹤0.01%	415

Other funds holding ALNY

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Decker Retirement Planning's ALNY Position: Q2 2026 in Review

Decker Retirement Planning opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 1 share worth $301. The stake represents ﹤0.01% of the portfolio and ranks #415 among its holdings.

206 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Decker Retirement Planning held 1 share of Alnylam Pharmaceuticals worth $301 as of Q2 2026.
Alnylam Pharmaceuticals was a new Decker Retirement Planning position in Q2 2026.
Alnylam Pharmaceuticals made up ﹤0.01% of Decker Retirement Planning's portfolio in Q2 2026, its #415 holding.
206 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Decker Retirement Planning's 13F filing for Q2 2026, filed 16 Jul 2026.